Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Phenome based analysis as a means for discovering context dependent clinical reference ranges.

Warner JL, Alterovitz G.

AMIA Annu Symp Proc. 2012;2012:1441-9. Epub 2012 Nov 3.

2.

Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications.

Warner JL, Zollanvari A, Ding Q, Zhang P, Snyder GM, Alterovitz G.

J Am Med Inform Assoc. 2013 Dec;20(e2):e281-7. doi: 10.1136/amiajnl-2013-001861. Epub 2013 Aug 1.

3.

Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.

Bauer MP, Hensgens MP, Miller MA, Gerding DN, Wilcox MH, Dale AP, Fawley WN, Kuijper EJ, Gorbach SL.

Clin Infect Dis. 2012 Aug;55 Suppl 2:S149-53. doi: 10.1093/cid/cis340.

4.

The host immune response to Clostridium difficile.

Kelly CP, Kyne L.

J Med Microbiol. 2011 Aug;60(Pt 8):1070-9. doi: 10.1099/jmm.0.030015-0. Epub 2011 Mar 17. Review.

PMID:
21415200
5.

The epidemiological and clinical analysis of Clostridium difficile infections in patients hospitalized due to the infection at the Department of Infectious Diseases in Bytom.

Stolarz W, Sobala-Szczygieł B, Piotrowski D, Kępa L, Oczko-Grzesik B, Boroń-Kaczmarska A.

Przegl Epidemiol. 2015;69(4):711-6, 857-60. English, Polish.

6.

Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.

Schmiedeskamp M, Harpe S, Polk R, Oinonen M, Pakyz A.

Infect Control Hosp Epidemiol. 2009 Nov;30(11):1070-6. doi: 10.1086/606164.

PMID:
19803724
7.

Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea.

Bulusu M, Narayan S, Shetler K, Triadafilopoulos G.

Am J Gastroenterol. 2000 Nov;95(11):3137-41.

PMID:
11095331
8.
9.

Outcome of ICU patients with Clostridium difficile infection.

Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Français A, Vesin A, Nguile-Makao M, Tabah A, Laupland K, Le-Monnier A, Timsit JF; OUTCOMEREA study group..

Crit Care. 2012 Nov 5;16(6):R215. doi: 10.1186/cc11852.

10.

Epidemiological study of Clostridium difficile infection in critical patients admitted to the Intensive Care Unit.

Alvarez-Lerma F, Palomar M, Villasboa A, Amador J, Almirall J, Posada MP, Catalan M, Pascual C; ENVIN-UCI Study Group..

Med Intensiva. 2014 Dec;38(9):558-66. doi: 10.1016/j.medin.2013.11.007. Epub 2014 Feb 3. English, Spanish.

11.

Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.

Penziner S, Dubrovskaya Y, Press R, Safdar A.

Antimicrob Agents Chemother. 2015 Mar;59(3):1776-81. doi: 10.1128/AAC.04268-14. Epub 2014 Dec 22.

12.

Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: a controlled interrupted time series study.

Taggart LR, Leung E, Muller MP, Matukas LM, Daneman N.

BMC Infect Dis. 2015 Oct 29;15:480. doi: 10.1186/s12879-015-1223-2.

13.

Preventing clostridium difficile infection in the intensive care unit.

Zilberberg MD, Shorr AF.

Crit Care Clin. 2013 Jan;29(1):11-8. doi: 10.1016/j.ccc.2012.10.006. Review.

PMID:
23182524
14.

A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.

Scawn N, Saul D, Pathak D, Matata B, Kemp I, Stables R, Lane S, Haycox A, Houten R.

Health Technol Assess. 2012 Sep;16(36):i-xiii, 1-70.

15.

Is Clostridium difficile infection an increasingly common severe disease in adult intensive care units? A 10-year experience.

Bouza E, Rodríguez-Créixems M, Alcalá L, Marín M, De Egea V, Braojos F, Muñoz P, Reigadas E.

J Crit Care. 2015 Jun;30(3):543-9. doi: 10.1016/j.jcrc.2015.02.011. Epub 2015 Feb 28.

PMID:
25791766
16.

Clostridium difficile in the ICU: study of the incidence, recurrence, clinical characteristics and complications in a university hospital.

Salva S, Duran N, Rodriguez V, Nieto L, Serra J, Rello J; CRIPS Investigators..

Med Intensiva. 2014 Apr;38(3):140-5. doi: 10.1016/j.medin.2013.03.012. Epub 2013 Jun 14.

17.

Clostridium difficile: association with thrombocytosis and leukocytosis.

Albrich WC, Rimland D.

South Med J. 2007 Feb;100(2):149-51.

PMID:
17330684
18.

Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality.

Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, Alam HB, DeMoya MA, Velmahos GC.

Arch Surg. 2009 May;144(5):433-9; discussion 439-40. doi: 10.1001/archsurg.2009.51.

PMID:
19451485
19.

Managing Clostridium difficile infection in hospitalised patients.

Denton A, Topping A, Humphreys P.

Nurs Stand. 2014 Apr 16-22;28(33):37-43. doi: 10.7748/ns2014.04.28.33.37.e8461. Review.

PMID:
24734836
20.

Clostridium difficile-associated disease: new challenges from an established pathogen.

Sunenshine RH, McDonald LC.

Cleve Clin J Med. 2006 Feb;73(2):187-97. Review.

PMID:
16478043

Supplemental Content

Support Center